IDiyas

For the Inventor, By the Inventor

Bresso, Italy

Piero Melloni

USPTO Granted Patents = 47


 

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 206(Granted Patents)


Location History:

  • Bresso, Milan, IT (1978 - 1979)
  • Bresso MI, IT (1995)
  • Milan, IT (1978 - 1999)
  • Bresso, IT (1980 - 2017)

Company Filing History:

goldMedal23 out of 343 
 
Sigma-tau Industrie Farmaceutiche Riunite S.p.a.
 patents
silverMedal11 out of 40 
 
Newron Pharmaceuticals S.p.a.
 patents
bronzeMedal5 out of 181 
 
Farmitalia Carlo Erba S.p.a.
 patents
4. 4 out of 140 
 
Farmitalia Carlo Erba S.r.l.
 patents
5. 4 out of 31 
 
Carlo Erba S.p.a.
 patents

Years Active: 1978-2017

Loading Chart...
Loading Chart...
Loading Chart...
47 patents (USPTO):Explore Patents
1. 9603832 - Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2017-03-28),
2. 9585869 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2017-03-07),
3. 9474739 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2016-10-25),
4. 9474738 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2016-10-25),
5. 9474737 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2016-10-25),
6. 9248116 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2016-02-02),
7. 9051240 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2015-06-09),
8. 8519000 - Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators (2013-08-27),
9. 7709523 - Alpha-aminoamide derivatives useful as antimigraine agents (2010-05-04),
10. 7649005 - Substituted benzylaminoalkylene heterocycles (2010-01-19),
11. 7265244 - Cyclopentyl derivatives (2007-09-04),
12. 7247747 - Process for preparing R-(-)carnitine from S-(-)-chlorosuccinic acid or from a derivative thereof (2007-07-24),
13. 6984739 - Process for preparing R-(−)-carnitin from S-(−)-chlorosuccinic acid or from a derivative thereof (2006-01-10),
14. 6677476 - Process for preparing R-(-) -carnitine from S-(-)-chlorosuccinic acid or from a derivative thereof (2004-01-13),
15. 5955632 - Seco-d steroids active on the cardiovascular system, processes for their (1999-09-21),

Title: Piero Melloni: Innovator from Bresso, Italy

Introduction: Piero Melloni is a renowned inventor hailing from Bresso, Italy, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Piero Melloni's latest patents include advancements in renewable energy technologies, sustainable materials, and cutting-edge medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Piero Melloni has been instrumental in developing revolutionary solutions that have significantly impacted industries such as healthcare, environmental sustainability, and consumer electronics. His ability to blend creativity with technical expertise has led to the creation of patents that have set new standards in innovation.

Collaborations: Piero Melloni has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His partnerships have been crucial in translating his ideas into tangible products that have improved the lives of many.

Conclusion: Piero Melloni's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his reputation as a pioneering inventor in the global landscape. His relentless pursuit of excellence continues to inspire the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…